Abstract
ATL is a rare but a highly aggressive T-cell neoplasm associated with human T-cell leukemia virus-1 (HTLV-1) infection. Human T-cell lymphotropic virus type-1 (HTLV-1) is a oncogenic retrovirus responsible for the development of adult T-cell leukemia (ATL), but also for other non-malignant diseases, such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 has a higher prevalence in Japan, the Caribbean, South America, intertropical Africa, Romania, and northern Iran. ATL patients can have an extensive spectrum of neurological manifestations. Numerous factors can be implicated, such as central nervous system infiltrates, neurolymphomatosis, complications to medication or allogeneic stem cell transplantation, HAM/TSP, infections, metabolic disturbances. The neurological complications are not always easy to recognize and treat. Thus, this review underlines the necessity of a multidisciplinary approach in ATL patients with neurological symptomatology.
Reference108 articles.
1. Gessain, A., and Cassar, O. European Centre for Disease Prevention and Control. Geographical Distribution of Areas with a High Prevalence of HTLV-1 Infection, 2015.
2. HTLV-I in Romania;Paun;Eur. J. Haematol.,1994
3. Results from Treatment of a Large Cohort of ATL Patients from a Country with High HTLV1 Prevalence;Bumbea;Blood,2019
4. Adult T-Cell Leukemia: Clinical and Hematologic Features of 16 Cases;Uchiyama;Blood,1977
5. Adult T-Cell Leukemia: A Review of Epidemiological Evidence;Iwanaga;Front. Microbiol.,2012
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献